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1382Objective: This study compared safety and efficacy between off-pump coronary artery bypass grafting
(OPCAB), a relatively new technique, and conventional on-pump coronary artery bypass grafting (CCAB) in
patients with left main stem disease.
Methods: In a retrospective, observational, cohort study of prospectively collected data on 2375 consecutive
patients with left main stem disease undergoing isolated CABG (1297 OPCAB, 1078 CCAB) between April
1996 and December 2009 at the Bristol Heart Institute, 548 patients undergoing OPCAB were matched with
548 patients undergoing CCAB by propensity score.
Results:After propensity matching, groups were comparable in preoperative characteristics. Relative to CCAB,
OPCAB was associated with lower in-hospital mortality (0.5% vs 2.9%; P¼ .001), incidence of stroke (0% vs
0.9%; P¼ .02), postoperative renal dysfunction (4.9% vs 10.8%; P¼ .001), pulmonary complications (10.2%
vs 16.6%; P¼ .002), and infectious complications (3.5% vs 6.2%; P¼ .03). The OPCAB group received fewer
grafts than did the CCAB group (2.7  0.7 vs 3  0.7; P ¼ .001) and had a lower rate of complete revascular-
ization (88.3% vs 92%; P ¼ .04). In multivariable analysis, cardiopulmonary bypass was confirmed to be an
independent predictor of in-hospital mortality (odds ratio, 5.74; P ¼ .001). Survivals at 1, 5, and 10 years
were similar between groups (OPCAB, 96.8%, 87.3%, and 71.7%; CCAB, 96.8%, 88.6%, and 69.8%).
Conclusions: OPCAB in patients with left main stem disease is a safe procedure with reduced early morbidity
and mortality and similar long-term survival to conventional on-pump revascularization. (J Thorac Cardiovasc
Surg 2012;143:1382-8)The presence of significant left main stem (LMS) coronary
artery disease is a well-known risk factor for cardiac-related
events and is associated with a 3-year survival as low as
37%, depending on the degree of stenosis, left ventricular
function, and associated coronary disease.1,2 Medical
therapy alone confers a poor survival advantage relative
to surgical revascularization,1,3,4 and the role of
percutaneous revascularization techniques for critical
LMS disease remains unclear.5,6 Off-pump coronary artery
bypass grafting (OPCAB) is now an established procedure,
with results comparable to conventional coronary artery by-
pass (CCAB) with cardiopulmonary bypass.7-9 Because of
the hemodynamic instability associated with ventricular
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The Journal of Thoracic and Cardiovascular Surartery disease have generally been excluded from OPCAB
revascularization.10,11 Previous studies investigating the
role of OPCAB in patients with LMS coronary artery
disease have reported on small cohorts of patients and
have lacked statistical adjustment to reduce the
differences in selection bias.12-14 The aim of this study
was therefore to evaluate the early outcomes and long-
term survivals after OPCAB versus CCAB in a consecutive
large cohort of patients with LMS coronary artery disease
by conducting a propensity score matching analysis.
MATERIALS AND METHODS
Patient Selection
The study was approved by the clinical audit committee of the Univer-
sity Hospital Bristol NHS Foundation Trust to meet ethical and legal re-
quirements, and individual consent was waived. This was a retrospective,
observational cohort study of prospectively collected data from consecu-
tive patients with LMS coronary artery diseasewho underwent isolated cor-
onary artery bypass grafting at the Bristol Heart Institute between April
1996 and December 2009. The data collection form was entered into a da-
tabase (Patient Analysis & Tracking System; Dendrite Clinical Systems,
London, UK) and included 5 sections that were filled in consecutively by
anesthetists, surgeons, and intensive care unit, high-dependency unit, and
ward nurses. The resulting base sample contained detailed clinical informa-
tion on 2375 patients, 1297 (54.6%) of whom underwent OPCAB and 1078
(45.4%) of whom underwent CCAB. To reduce the effect of treatment se-
lection bias and potential confounding, we used a propensity score match-
ing analysis,15 which resulted in 548 patients who underwent OPCAB
matched with an equal number of patients who underwent CCAB.gery c June 2012
Abbreviations and Acronyms
CCAB ¼ conventional coronary artery bypass
grafting
LMS ¼ left main stem
NSTS ¼ National Strategic Tracing Service
OPCAB ¼ off-pump coronary artery bypass
grafting
Murzi et al Acquired Cardiovascular Disease
A
C
DDefinitions
Critical LMS disease was defined as a stenosis of greater than 50% ac-
cording to visual assessment of the preoperative coronary angiogram by
the referring physician. In-hospital mortality included all deaths within
30 days of operation regardless of where death occurred and all deaths
in hospital after 30 days among patients who had not been discharged af-
ter the index operation. A diagnosis of postoperative myocardial infarc-
tion was based on the presence of new Q waves longer than 0.04 ms or
a reduction in R waves greater than 25% in at least 2 contiguous leads
on electrocardiography. The need for pacing, arrhythmias, and inotropic
requirements were recorded and defined as previously reported else-
where.14 Pulmonary complications included chest infection, ventilation
failure, reintubation, and tracheostomy.16 Postoperative blood loss was
defined as total chest tube drainage. Neurologic complications included
permanent and transient strokes. Renal complications included acute renal
failure, defined as the requirement of hemodialysis or an elevated creati-
nine level (>200 mmol/L). Infectious complications included septicemia
and sternal and leg wound infections, defined by positive culture and re-
quirement for antibiotic therapy.14
The completeness of revascularization was determined by comparing
the number of distal anastomoses with the number of diseased coronary
systems observed on the preoperative coronary angiogram. If the number
of distal anastomoses performed equaled the total number of coronary sys-
tems with significant disease, the completeness of revascularization index
was 1. Patients who had more distal anastomoses performed than the num-
ber of vessels with angiographically significant disease had a completeness
of revascularization index greater than 1 and were classified as having com-
plete revascularization.
Patient Survival
Patient records were linked to the National Strategic Tracing Service
(NSTS), which records all deaths in the United Kingdom. To establish cur-
rent vital status, patients were matched against the NSTS according to
name, National Health Service unique number, date of birth, sex, and postal
code. All patients in this studywere successfullymatched against the NSTS
database.
Anesthetic, Surgical Technique, and Postoperative
Management
Anesthetic and surgical techniques were standardized for all patients
and have been reported previously elsewhere.10,16 In brief, for patients
undergoing CCAB, cardiopulmonary bypass was instituted with the use
of ascending aortic cannulation and 2-stage venous cannulation of the right
atrium. The membrane oxygenator was primed with 1000 mL of Hartman
crystalloid solution, 500 mL of Gelofusine (B. Braun Melsungen AG, Mel-
sungen, Germany), 0.5-g/kg mannitol, 7 mL 10% calcium gluconate, and
6000 IU heparin. Alpha-stat pH management was used, and the systemic
temperature was kept between 34C and 36C. Myocardial protection
was achieved with intermittent hyperkalemic antegrade warm blood cardi-
oplegia.17,18 For OPCAB surgery, the Bristol technique was used to expose
the coronaries and provide stabilization to perform the anastomoses.10 AtThe Journal of Thoracic and Carthe end of surgery, patients were transferred to the intensive care unit
and managed according to the unit protocol.10,16
Statistical Analysis
Continuous data were expressed as mean SD, and categoric data were
expressed as percentages. The Kolmogorov-Smirnov test was used to check
for normality of data in the 2 groups before further analysis. Differences
between OPCAB and CCAB groups were compared with the use of a c2
test for categoric variables and t orWilcoxon rank sum tests, as appropriate,
for continuous variables. To reduce the effects of selection bias and poten-
tial confounding in this observational study, we developed a propensity
score analysis. The propensity for OPCAB was determined without regard
to outcomes by the use of a nonparsimonious multiple logistic regression
analysis. All the variables listed in Table 1, the surgeons (proficient in OP-
CAB or CCAB), as well as years of operation (number of days of each op-
eration fromApril 1 1996, divided by 365) were included in the analysis. A
propensity score, indicating the predicted probability of receiving OPCAB
treatment, was then calculated from the logistic equation for each patient.
Finally, we used the propensity score tomatch patients undergoing OPCAB
with those undergoing CCAB (1:1 match). Specifically, we matched each
patient undergoing OPCAB patient with 1 undergoing CCAB who had
a propensity score that was identical to 5 places. If this could not be
done, we then proceeded to the next highest digit match (4-, 3-, 2-, and
1-digit) to make the best matches, in a hierarchic sequence until no more
matches could be made. Stepwise, multivariable logistic regression model-
ing was used to identify independent risk factors for in-hospital mortality;
a significance level of .05 was used for both entry and selection. Similarly,
multivariable Cox proportional hazard modeling was used to identify inde-
pendent risk factors for all-cause mortality. Covariates under consideration
for all models were all baseline characteristics (as listed in Table 1), the
completeness of revascularization, and the use of cardiopulmonary bypass.
Results are reported as percentages and odds ratios or hazards ratios and
95% confidence intervals. Overall survival was estimated by using the
Kaplan-Meier method and was expressed as a percentage. Differences in
long-term survivals were assessed by log-rank tests.
All reported P values are 2-sided. All statistical analyses were per-
formed with SPSS statistical software (version 15.0; IBM Corporation, Ar-
monk, NY) and StatsDirect statistical software (version 2.7.2; StatsDirect
Ltd, Altrincham, UK).
RESULTS
During the study period, 2375 patientswith LMScoronary
artery disease underwent isolated coronary artery bypass
grafting; of these, 1297 patients (54.6%) underwentOPCAB
and 1078 (45.4%) underwent CCAB. Baseline characteris-
tics of the study population are shown in Table 1. Compared
with theCCABgroup, patientswhounderwentOPCABwere
older, had a higher prevalence of hypertension, and were
more likely to require an urgent operation. In addition, they
hadmore limited coronary artery disease andbetterCanadian
Cardiovascular Society functional class and NewYork Heart
Association (NYHA) functional class.
After propensity score matching, there were 548 matched
pairs of patients (Table 1). In the matched cohorts, there was
no longer any significant difference between the 2 groups
for any covariate. OPCAB was associated with lower early
mortality than was CCAB (P ¼ .001). Moreover, patients
undergoing OPCAB were less likely to have stroke
(P ¼ .02), postoperative renal dysfunction (P ¼ .001),
pulmonary complications (P ¼ .002), and infectiousdiovascular Surgery c Volume 143, Number 6 1383
TABLE 1. Baseline characteristics of the entire cohort and propensity-matched patients
Variable
All patients Propensity-matched patients
OPCAB
(n ¼ 1297)
CCAB
(n ¼ 1078) P value
OPCAB
(n ¼ 548)
CCAB
(n ¼ 548) P value
Age (y, mean  SD) 66.4  9.2 64.5  9 .001 65.7  9.3 66.2  8.7 .3
Body mass index (kg/m2, mean  SD) 28.2  5.1 27.9  4.8 .2 27.4  0.5 27.2  0.4 .2
Female sex (no.) 233 (24.8%) 1047 (25.1%) .8 109 (19.7%) 105 (19.2%) .7
Canadian Cardiovascular Society class (mean  SD) 2.5  1.1 2.6  1 .01 2.5  1.1 2.5  1.1 .7
New York Heart Association functional class (mean  SD) 2  0.8 2.1  0.8 .01 2  0.8 2  0.7 .6
Diabetes mellitus (no.) 257 (19.8%) 205 (19%) .6 114 (20.8%) 113 (20.6%) .9
Hypertension (no.) 948 (73.1%) 717 (66.5%) .01 383 (69.9%) 387 (70.6%) .8
Cerebrovascular disease (no.) 114 (8.8%) 88 (8.2%) .5 46 (8.4%) 53 (9.7%) .4
Vascular disease (no.) 147 (11.3%) 100 (9.3%) .1 51 (9.3%) 61 (11.1%) .3
Chronic obstructive pulmonary disease (no.) 155 (12%) 113 (10.5%) .2 64 (11.7%) 67 (12.2%) .8
History of atrial fibrillation (no.) 43 (3.3%) 3.4 (3.2%) .9 18 (3.3%) 15 (2.7%) .6
Creatinine (mol/L, mean  SD) 109  37 111  34 .1 112  47 111  37 .7
Ejection fraction<30% (no.) 63 (4.9%) 66 (4.1%) .08 29 (5.3%) 24 (4.4%) .5
Previous myocardial infarction (no.) 573 (44.2%) 508 (47.1%) .1 252 (51.2%) 272 (47.8%) .6
Previous percutaneous coronary intervention (no.) 64 (4.9%) 43 (4%) .2 24 (4.4%) 25 (4.6%) .9
Reoperative surgery (no.) 25 (1.9%) 62 (1.6%) .4 10 (1.8%) 14 (1.6%) .4
Preoperative intra-aortic balloon pump use (no.) 21 (1.6%) 26 (2.4%) .1 18 (3.3%) 12 (3.1%) .2
Urgent operation (no.) 795 (61.3%) 291 (27%) .001 241 (44.1%) 231 (42.3%) .5
EuroSCORE (no.) 4.1  2.8 4.5  3.2 .07 4.1  2.7 4.1  2.7 .7
Diseased coronary arteries (mean  SD) 2.67  0.5 2.78  0.5 .001 2.71  0.5 2.71  0.4 .1
OPCAB, Off-pump coronary artery bypass grafting; CCAB, conventional coronary artery bypass grafting.
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CCAB. Patients undergoing OPCAB a significantly lower
needs for postoperative intra-aortic balloon pump
(P ¼ .03) and inotropic supports (P ¼ .004), but no differ-
ence was found in the incidence of postoperative myocar-
dial infarction (P ¼ .5; Table 2).TABLE 2. Clinical outcomes of propensity-matched patients
Variables
O
(
No. of grafts (mean  SD) 2
Completeness of revascularization index (mean  SD)
Complete revascularization (no.) 48
In hospital mortality (no.)
Perioperative myocardial infarction (no.) 2
Postoperative atrial fibrillation (no.) 11
Postoperative intra-aortic balloon pump (no.) 1
Inotropic support (no.) 20
Transient cerebrovascular accident (no.)
Permanent cerebrovascular accident (no.)
Renal dysfunction (no.) 2
Hemodialysis (no.)
Infectious complications 1
Gastrointestinal complications (no.)
Pulmonary complications (no.) 5
Blood loss (mL, mean  SD) 7
Reoperation for bleeding
Intensive care unit stay (d, mean  SD) 1
Hospital stay (d, mean  SD) 8
OPCAB, Off-pump coronary artery bypass grafting; CCAB, conventional coronary artery
1384 The Journal of Thoracic and Cardiovascular SurThe OPCAB group received fewer coronary grafts (2.7 
0.7 vs 3 0.7; P¼ .001) than the CCAB group and also had
a lower completeness of revascularization index (1  0.3 vs
1.1 0.3;P¼ .01) and a lower rate of completeness of revas-
cularization (P¼ .04) than the CCAB group. In addition, the
OPCABgrouphada shorter intensive care unit stay (P¼ .01).PCAB
n ¼ 548)
CCAB
(n ¼ 548) P value
.7  0.7 3  0.7 .001
1  0.3 1.1  0.3 .001
4 (88.3%) 504 (92%) .04
3 (0.5%) 16 (2.9%) .001
5 (4.6%) 20 (3.6%) .5
3 (20.6%) 147 (26.8%) .01
4 (2.6%) 27 (4.9%) .03
8 (38%) 255 (46.5%) .004
2 (0.4%) 2 (0.4%) .9
0 (0%) 5 (0.9%) .02
7 (4.9%) 59 (10.8%) .001
3 (0.5%) 8 (1.5%) .1
9 (3.5%) 34 (6.2%) .03
4 (0.7%) 7 (1.3%) .3
6 (10.2%) 91 (16.6%) .002
68  382 814  461 .4
8 (1.5%) 15 (2.7%) .1
.34  1.1 1.48  1.1 .04
.1  0.2 8.5  0.2 .5
bypass grafting.
gery c June 2012
TABLE 3. Multivariate analysis of in-hospital and long-term mortalities in propensity-matched patients
Variable Odds/hazard ratio 95% Confidence interval P value
In-hospital mortality
Cardiopulmonary bypass 5.74 1.33–37.24 .001
Diabetes 3.48 1.46–15.64 .03
Urgent operation 5.83 1.42–24.35 .001
Long-term mortality
Age 1.053 1.030–1.076 .001
Diabetes 1.407 0.981–2.018 .05
COPD 1.558 1.011–2.401 .04
Vascular disease 1.932 1.266–2.950 .002
Incomplete revascularization 1.533 0.942–2.496 .086
COPD, Chronic obstructive pulmonary disease.
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use of cardiopulmonary bypass was an independent risk fac-
tor for in-hospital morality (odds ratio, 5.74; 95% confi-
dence interval, 1.33–37.24; P ¼ .001). Other independent
predictors of mortality included diabetes and operative
priority (Table 3).
Follow-up (100% complete) was similar between the 2
groups (OPCAB, 50.5  31.2 months vs CCAB, 54.4 
34.1 months; P ¼ .5). The 1-, 5- and 10-year survivals
were similar in the 2 groups (OPCAB, 96.8%, 87.3%,
and 71.7% vs CCAB, 96.8%, 88.6%, and 69.8%;
Figure 1). Advanced age, chronic obstructive pulmonary
disease, diabetes, peripheral vascular disease, and incom-
plete revascularization were associated with reduced sur-
vival (Table 3). Finally, CCAB was not associated with
worse survival than was OPCAB. During the study period,
there was a steady increase in the use of OPCAB to treat pa-
tients with LMS coronary artery disease, from 2.0% of the
total in 1996 to 50% in 2001 and 75.3% in 2009. ClinicalFIGURE 1. Kaplan-Meier survival curves for the propensity-matched pa-
tients.OPCAB,Off-pump coronary artery bypass grafting; CCAB, conven-
tional on-pump coronary artery bypass grafting.
The Journal of Thoracic and Caroutcomes of the entire cohort study population are reported
in Appendix 1 and 2.
DISCUSSION
Our study demonstrates that OPCAB is safe for patients
with LMS coronary artery disease and is associated with
improved early morbidity and mortality and similar long-
term survival with respect to CCAB.
Hemodynamic instability that may occur while perform-
ing revascularization on a beating heart is often cited as the
main reason for not using the OPCAB technique to treat pa-
tients with critical LMS disease.10,11 After encouraging
early pioneering results,19,20 however, a few studies have
suggested potential benefits of OPCAB in this group of
patients. Dewey and colleagues12 reported a lower perioper-
ative mortality among 100 patients undergoing OPCAB
compared with 723 undergoing CCAB and identifying the
use of cardiopulmonary bypass as an independent predictor
of in-hospital mortality (hazard ratio, 7.3; 95% confidence
interval, 1.3–138.3). Virani and associates13 showed similar
mortalities in both groups, and a study from our institution
reported lower requirements for inotropes and transfusion
and a slightly shorter hospital stay for OPCAB compared
with CCAB.14 Lu and associates21 analyzed the results of
1197 patients with LMS coronary artery disease (259 OP-
CAB vs 938 CCAB). They reported comparable outcomes
between the 2 groups and concluded that LMS coronary
artery disease should not represent a contraindication to
OPCAB. All these studies were carried out on relatively
small numbers of patients undergoing OPCAB and often re-
flected the initial experience of these Institutions with the
technique. In contrast, our study is based on a large cohort
of patients operated on over a period of 15 years. The num-
ber of patients presenting with a LMS coronary artery dis-
ease and the use of OPCAB steadily increased during the
study period, reflecting our increasing experience with the
technique.
The theoretic and practical advantages of avoiding car-
diopulmonary bypass and related systemic inflammatory re-
sponse may have contributed in our study to the lower ratediovascular Surgery c Volume 143, Number 6 1385
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tions, and infectious complications in our OPCAB group
relative to our CCAB group. The global ischemia associated
with cardiopulmonary bypass and cardioplegic arrest might
explain the higher requirements of postoperative inotropic
support and intra-aortic balloon pump use observed in the
CCAB group relative to the OPCAB group.
The myocardial protection used in our study has been
suggested to be associated with a higher incidence of myo-
cardial necrosis and dysfunction, especially during the re-
vascularization of the acutely ischemic myocardium,22
and retrograde cardioplegia has been proposed as a superior
technique. Drawbacks associated with retrograde perfusion,
however, such as myocardial edema and coronary sinus rup-
ture, have caused many investigators to support the ante-
grade route alone even for patients with severe coronary
artery disease.23,24 At the Bristol Heart Institute, we have
used intermittent antegrade warm blood cardioplegia
supplemented with magnesium since 1996 and have
demonstrated its efficacy and safety.17,18 All these studies
included urgent operations and patients in unstable
condition and have consistently shown good hospital
outcomes and lower release of markers of myocardial
injury.
Patients undergoing OPCAB received fewer grafts and
had a lower rate of completeness of revascularization than
did those undergoing CCAB. This finding is consistent
with other reports.3-14 Our database does not contain
variables on the quality of coronary arteries, so it is
difficult to know whether this difference in completeness
of revascularization was due to patient characteristics or
to technical challenges with the OPCAB procedure.
Despite incomplete revascularization in the OPCAB
group, survivals at 1, 5, and 10 years were similar
between the 2 groups.
It is possible that a longer follow-up period might reveal
a decreased long-term survival associated with incomplete
revascularization in OPCAB. Indeed, it is important to
note that when comparing the entire cohort study popula-
tion, OPCAB was associated with both a higher incidence
of incomplete revascularization and a reduced long-term
survival relative to (Appendix 1 and 2).
Study Limitations
This study is based on a retrospective analysis of our
large, institutional, observational, prospectively collected
database. Propensity score analysis is simply a method to
reduce bias in observational studies, and the matching
was limited by available variables. The definition we used
for revascularization is likely to have overestimated the pro-
portion of patients who had completeness of revasculariza-
tion, because patients may have had more than 1 graft to the
same coronary system. The definition has the advantage of
being simple and transparent, however, and the Bypass1386 The Journal of Thoracic and Cardiovascular SurAngioplasty Revascularization Investigation investigators
found that their results were not markedly affected by using
different definitions, including that used here.25
Even though the multivariable logistic regression identi-
fied the use of cardiopulmonary bypass as an independent
predictor of in-hospital mortality, this analysis is limited
by the low number of events (19 deaths), which may have
affected the result, as shown by a wide confidence interval.
Another limitation of this study is the use of all-cause mor-
tality data, reliably obtained from the NSTS, rather than the
more specific but less readily available cardiac-related
mortality data. The study also did not address the relative
incidences of nonfatal cardiac-related events and the re-
quirements for repeated revascularization between the
respective groups during the follow-up period.CONCLUSIONS
In conclusion, our study demonstrates that in patients
with LMS disease, OPCAB surgery is safe and associated
with improved early clinical outcomes and similar long
term survival compared with CCAB. A longer follow-up
is required to understand the effects of incomplete revascu-
larization in this subset of patients.References
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APPENDIX 2. Clinical outcomes of the entire cohort study population
Variables
OPCAB
(n ¼ 1297)
CCAB
(n ¼ 1078) P value
No. of grafts (mean  SD) 2.7  0.7 3  0.7 .001
Completeness of revascularization index (mean  SD) 1  0.3 1.1  0.3 .001
Complete revascularization (no.) 1126 (86.7%) 992 (92.1%) .001
In-hospital mortality (no.) 11 (0.8%) 30 (2.8%) .001
Perioperative myocardial infarction (no.) 45 (3.5%) 31 (2.9%) .4
Postoperative atrial fibrillation (no.) 276 (21.3%) 296 (27.5%) .001
Postoperative intra-aortic balloon pump (no.) 33 (2.6%) 43 (4.5%) .01
Inotropic support (no.) 509 (39.2%) 527 (48.9%) .001
Transient cerebrovascular accident (no.) 3 (0.2%) 4 (0.4%) .5
Permanent cerebrovascular accident (no.) 1 (0.1%) 8 (0.7%) .01
Renal dysfunction (no.) 84 (6.5%) 115 (10.7%) .001
Hemodialysis (no.) 8 (0.6%) 20 (1.9%) .005
Infectious complications (no.) 44 (3.4%) 65 (6%) .002
Gastrointestinal complications (no.) 17 (1.3%) 15 (1.4%) .8
Pulmonary complications (no.) 146 (11.2%) 181 (16.8%) .001
Blood loss (mL, mean  SD) 812  671 848  743 .2
Reoperation for bleeding (no.) 24 (1.8%) 43 (4%) .002
Intensive care unit stay (d, mean  SD) 1.4  1 1.8  2.2 .01
Hospital stay (d, mean  SD) 8.1  0.2 8.5  0.2 .5
OPCAB, Off-pump coronary artery bypass grafting; CCAB, conventional coronary artery bypass grafting.
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